EDITORIAL INDICATES TESTOSTERONE MAY BE OVERSOLD IN THE U.S.
On February 4, 2014, the New York Times published an editorial indicating that drugs used to treat a medical condition known as “low T” are possibly being oversold in the U.S.
NO FEE UNLESS WE WIN
FREE CASE REVIEW
800-247-1623
On February 4, 2014, the New York Times published an editorial indicating that drugs used to treat a medical condition known as “low T” are possibly being oversold in the U.S.
The results of a recent study published in PLoS ONE found that in “older men, and in younger men with pre-existing diagnosed heart disease, the risk of MI [myocardial infarction] following initiation of [testosterone therapy] prescription is substantially increased.”
In November 2013, the Journal of the American Medical Association (JAMA) published the results of a study that sought to understand the relationship between testosterone therapy intake and health issues in men, particularly heart attack and stroke.
In recent months, there has been an increasing amount of evidence indicating that testosterone therapy may cause serious and permanent injuries resulting from heart attack and strokes in patients.
On January 31, 2014, the U.S. Food and Drug Administration (FDA) issued a safety alert indicating the agency will investigate whether an association exists between the use of FDA-approved testosterone products and the increased risk of stroke, heart attack and death in men.
HPV (“human papillomavirus”) is a common virus that can be passed from one person to another during sex.
Texas Department of Transportation (TxDOT) is working in conjunction with the Texas Department of Public Safety to spread the word about its safety initiative for drivers in energy work zones.
On November 25, 2013 and November 26, 2013, the New York Times published a series of articles regarding a recent lawsuit filed by ten former National Hockey League (NHL) players against the league.
The Federal Motor Carrier Safety Administration (FMCSA) maintains its National Consumer Complaint Database in order to allow consumers and other to notify the FMCSA regarding complaints against motor carriers.
According to the FDA, the answer is a resounding “No.”
On January 7, 2014, MyPlainview.com published an article regarding the large number of complaints
On December 15, 2013, the Oil & Gas Journal published an article regarding the growing
Get a Free Consultation. No Fees Unless We Win. We’re Here 24/7